- Home
- CTSO vs XBP Comparison
CTSO vs XBP Comparison
Compare CTSO & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- XBP
- Stock Information
- Founded
- CTSO 1997
- XBP 2020
- Country
- CTSO United States
- XBP United States
- Employees
- CTSO N/A
- XBP N/A
- Industry
- CTSO Medical/Dental Instruments
- XBP Business Services
- Sector
- CTSO Health Care
- XBP Consumer Discretionary
- Exchange
- CTSO Nasdaq
- XBP Nasdaq
- Market Cap
- CTSO 61.7M
- XBP 71.0M
- IPO Year
- CTSO N/A
- XBP N/A
- Fundamental
- Price
- CTSO $1.00
- XBP $0.85
- Analyst Decision
- CTSO Buy
- XBP
- Analyst Count
- CTSO 2
- XBP 0
- Target Price
- CTSO $5.50
- XBP N/A
- AVG Volume (30 Days)
- CTSO 123.9K
- XBP 536.9K
- Earning Date
- CTSO 11-06-2025
- XBP 08-14-2025
- Dividend Yield
- CTSO N/A
- XBP N/A
- EPS Growth
- CTSO N/A
- XBP N/A
- EPS
- CTSO N/A
- XBP N/A
- Revenue
- CTSO $36,107,520.00
- XBP $148,332,000.00
- Revenue This Year
- CTSO $11.93
- XBP N/A
- Revenue Next Year
- CTSO $21.22
- XBP N/A
- P/E Ratio
- CTSO N/A
- XBP N/A
- Revenue Growth
- CTSO 20.18
- XBP 0.23
- 52 Week Low
- CTSO $0.71
- XBP $0.42
- 52 Week High
- CTSO $1.61
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- CTSO 52.14
- XBP 61.94
- Support Level
- CTSO $0.94
- XBP $0.59
- Resistance Level
- CTSO $0.99
- XBP $0.63
- Average True Range (ATR)
- CTSO 0.07
- XBP 0.07
- MACD
- CTSO 0.01
- XBP 0.04
- Stochastic Oscillator
- CTSO 82.21
- XBP 86.25
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.